Introduction
============

Fibroblasts are migratory cells of the connective tissue playing important roles in wound healing and mediating the formation and remodeling of epithelial tissues ([@bib56]; [@bib20]). In vitro, cultured fibroblasts have been used as a model system for studying the signaling and mechanical processes of cell migration. A migrating fibroblast on a 2D matrix exhibits the stereotypical polarized morphology with an often fan-shaped front called the lamella and a tapered tail end ([@bib1]; [@bib2]). At the leading edge of the lamella, two types of protrusive structures are frequently observed, the ruffling veil-like lamellipodia and the thin, spike-like filopodia. Ultrastructural data showed that lamellipodia are composed of orthogonal arrays of actin filaments with branched actin filaments near the leading edge plasma membrane, whereas filopodia contain parallel bundles of actin filaments ([@bib8]). Elongation at the barbed ends of actin in lamellipodia and filopodia is thought to produce the protrusive force for leading edge advancement ([@bib39]; [@bib7]). Protein factors regulating actin polymerization at the leading edge are thus key components of the molecular machinery driving cell motility.

The Arp2/3 complex is an evolutionarily conserved actin nucleation factor localized in the lamellipodia ([@bib32]; [@bib63]; [@bib38]). The Arp2/3 complex is composed of seven stoichiometric subunits, including two actin-related proteins, Arp2 and Arp3, and five additional subunits, ARPC1--5 ([@bib28]; [@bib63]; [@bib66]; [@bib7]). Purified Arp2/3 complex does not (or poorly) stimulate actin nucleation, but in the presence of nucleation promoting factors, most importantly Wiskott-Aldrich Syndrome protein (WASP) family members, the Arp2/3 complex nucleates a new actin filament from the side of an existing filament ([@bib29]; [@bib33]; [@bib41]; [@bib67]; [@bib59]; [@bib43]). The resulting actin structures are highly reminiscent of the branched actin network observed in lamellipodia. ([@bib53]; [@bib69]). The Arp2/3 complex also nucleates branched actin network at the surface of the pathogenic bacteria, *Listeria monocytogenes*, as part of the actin comet tail propelling the bacterium's motility within host cell cytoplasm ([@bib64]; [@bib26]; [@bib31]; [@bib71]). These findings led to the dendritic nucleation model for the generation and extension of the lamellipodial actin network by the Arp2/3 complex ([@bib39]). In addition, debranching and bundling of the Arp2/3 complex--nucleated actin filaments is thought to be a major pathway for filopodia formation ([@bib54]; [@bib24]).

Although the dendritic nucleation model has been rigorously evaluated in several computational studies ([@bib30]; [@bib46]; [@bib45]), experimental evidence demonstrating a critical role for Arp2/3 in the generation of protrusive actin structures and cell motility has been far from clear. Although some of the studies using RNAi against Arp2/3 components or dominant-negative constructs derived from WASP family proteins concluded that disrupting the Arp2/3 inhibited lamellipodia formation or morphology ([@bib27]; [@bib3]; [@bib51]), one study reported a lack of effect on lamellipodia extension or morphology even after knocking down complex subunits by over 90% in mouse embryonic fibroblasts ([@bib9]). However, given that the Arp2/3 complex nucleates actin at nanomolar concentrations ([@bib19]), even a dramatic knockdown could still leave behind a level sufficient to fully or partially support Arp2/3-dependent functions. Importantly, none of the published studies analyzed in detail the impact of Arp2/3 complex inhibition on fibroblast cell motility.

The goal of this study is to genetically disrupt the Arp2/3 complex in order to determine its function in fibroblast cell motility. We derived mouse embryonic stem (ES) cell lines from isogenic ARPC3^−/−^ and ARPC3^+/+^ blastocysts. Differentiation of the ES cells into fibroblasts enabled us to perform detailed microscopy analyses comparing leading edge structures, dynamics, and motility behaviors between cells of these two genotypes in vitro. Our results show that in the absence of the Arp2/3 complex, fibroblasts are unable to form stereotypical lamellipodia or undergo sustained directional migration. The system developed in this study can be used for determining the role of the Arp2/3 complex in the motility of diverse cell types that can be differentiated from ES cells.

Results and discussion
======================

Generation of ARPC3^−/−^ and ARPC3^+/+^ ES cells and fibroblast differentiation
-------------------------------------------------------------------------------

Our initial choice of targeting the ARPC3 subunit of the Arp2/3 complex was due to the availability of a mouse ES cell line (Bay Genomics) bearing heterozygous gene-trap disruption of the single gene encoding ARPC3, the p21 subunit of the Arp2/3 complex. Biochemical analysis of the yeast and human Arp2/3 complexes previously showed that although a partial complex can exist in the absence of p21, the nucleation-promoting factor-stimulated actin nucleation is severely disrupted ([@bib14]; [@bib22]). The gene-trap cassette used by Bay Genomics contained a promoterless reporter/selectable marker fusion gene (βgeo) followed by a strong transcriptional termination sequence ([@bib65]; [@bib50]). In the ARPC3 gene-trap ES cell line (XG476), the gene trap was inserted in the second intron of the ARPC3 gene, leading to truncation of ARPC3 after exon 2 (at amino acid 36) by βgeo ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp1}), as confirmed by 5′ RACE PCR analysis. XG476 ES cells were used to generate ARPC3^+/−^ mice in the C57BL/6J genetic background (see Materials and methods). ARPC3^+/−^ adult mice appeared normal and fertile; however, no live ARPC3^−/−^ homozygous newborns were observed. Further genotyping of embryos from embryonic day E3.5, E8.5, and E10.5 indicated that ARPC3^−/−^ causes embryonic lethality as early as E3.5, the blastocyst stage (Fig. S1 B). A similar pre-implantation embryonic lethality was also reported in a study in which *ARPC3* was disrupted by transposon insertion ([@bib68]).

Although unable to undergo implantation and further development, the ARPC3^−/−^ blastocysts appeared to contain well-formed inner cell mass cells (Fig. S1 B), suggesting the possibility of using these blastocysts to derive ES cells. To this end, blastocysts were collected after mating of ARPC3^+/−^ parents and cultured individually on irradiated mouse embryonic fibroblast (iMEF) feeder layers in ES cell medium containing leukemia inhibiting factor (LIF). The genotype of the ES cells derived from each blastocyst was determined retrospectively by PCR assays of the genomic DNA ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp2}). The pluripotency of the resulting ARPC3^+/+^, ARPC3^+/−^, and ARPC3^−/−^ ES cell clones was assessed by using standard methods including anti-Oct4 immunofluorescence staining and the alkaline phosphatase assay (Fig. S2 B; [@bib55]; [@bib48]; [@bib23]; [@bib15]).

We used a previously established protocol to differentiate ES cells into fibroblasts. In brief, ES cells were separated from the feeder cells and then cultured without LIF but in the presence of retinoic acid for 7 d ([@bib49]). At the end of this culturing, the differentiated fibroblasts were separated from the remaining undifferentiated ES cells based on the ability of fibroblasts to rapidly readhere to fibronectin-coated substrate after trypsinization. The fibroblast identity of these differentiated cells was further confirmed by staining of a commonly used fibroblast marker, IB10 ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp3}; [@bib35]; [@bib42]). PCR genotyping was performed on the differentiated fibroblasts to reconfirm their genetic identity. RT-PCR showed that although full-length ARPC3 mRNA was detected in the ARPC3^+/+^ fibroblasts, no amplicon was observed in samples from ARPC3^−/−^ fibroblasts (Fig. S2 C), confirming disruption of ARPC3 expression by the gene trap as expected. Immunofluorescence showed no ARPC3 staining in the mutant cells, whereas lamellipodia staining was observed in ARPC^+/+^ cells (Fig. S3 B). Possibly as a result of the inability to form a full complex, immunoblotting showed that the protein level of Arp2 was dramatically reduced in the mutant compared with wild-type cells (Fig. S2 D).

ARPC3^−/−^ fibroblast cells are defective in the formation of lamellipodia
--------------------------------------------------------------------------

Although the differentiated fibroblasts of both ARPC3^+/+^ and ARPC3^−/−^ genotypes showed the flat morphology with protrusive edges as expected, it was readily apparent that whereas wild-type fibroblasts had smooth lamellipodia-like edges and some spiky protrusions that morphologically resembled filopodia, the mutant cells displayed jagged edges exclusively with the latter ([Fig.1](#fig1){ref-type="fig"}, A and B, arrows). Because the morphologies of the cells in each population were somewhat heterogeneous, depending on whether they were in contact with other cells or whether they were actively moving, we compared the morphology of protrusive cell edges in a spreading assay where the cells were expected to have a more uniform morphology. Cells were first detached from the substrate by trypsinization and then allowed to re-spread on fibronectin-coated coverslips, during which the morphology of the cells was recorded by time-lapse imaging. [Fig. 1, C and D](#fig1){ref-type="fig"}, show a montage of representative of ARPC3^+/+^ and ARPC3^−/−^ cells (also see [Videos 1](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp4} and [2](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp5}). All of the observed ARPC3^+/+^ cells that spread (*n* = 10) did so through highly uniform lamellipodia extension positive for phalloidin and anti-Arp2 staining ([Fig. 2 A](#fig2){ref-type="fig"}). By contrast, none of the ARPC3^−/−^ cells observed to spread (*n* = 10) showed veil-like edges, but instead spread through protrusions that contained actin bundles ([Fig. 2 A](#fig2){ref-type="fig"}) and fascin (Fig. S3 B), an actin-bundling protein found in filopodia ([@bib58]; [@bib72]; [@bib57]). For simplicity, the spiky, fascin-containing protrusions in the ARPC3^−/−^ fibroblasts are referred to hereafter as filopodia-like protrusions (FLPs). Interestingly, the mutant cells spread nearly as efficiently as the wild type ([Fig.1E](#fig1){ref-type="fig"}), although a slight deficiency is consistent with a previous study ([@bib34]).

![**ARPC3^−/−^ fibroblast cells are deficient in lamellipodia formation.** (A and B) Representative phase-contrast images showing the morphology of ARPC3^+/+^ (A) and ARPC3^−/−^ (B) fibroblast cells after 7 d of differentiation. Arrows indicate lamellipodia (wild type) and FLPs (mutant). Bar, 50 µm. (C and D) Time-lapse montage showing spreading morphology of ARPC3^+/+^ (C) and ARPC3^−/−^ cells (D) on 5 mg/ml fibronectin-coated glass surface. Frame interval is 15 min. Bars, 15 µm. (E) Quantification of cell area from experiments as described in C and D. Plots show mean and standard error of the mean (SEM) from 13 (APRC3^+/+^) and 11 (APRC3^−/−^) spreading cell movies made in three different experiments.](JCB_201112113_Fig1){#fig1}

![**Localization of Arp2 and mDia1 formin in ARPC3^+/+^ and ARPC3^−/−^ fibroblasts.** Spreading (A) or polarized (B) ARPC3^+/+^ and ARPC3^−/−^ cells were fixed and stained with AF546 phalloidin (red), the indicated antibodies (green), and DAPI (blue). Bars, 25 µm.](JCB_201112113_Fig2){#fig2}

Phalloidin staining of polarized ARPC3^+/+^ and ARPC3^−/−^ fibroblasts show that although the wild-type cells exhibit the typical actin organization with F-actin enriched at the lamellipodia leading edge and stress fibers extending into the lamella ([Fig. 2 B](#fig2){ref-type="fig"}), the leading edges of mutant cell are characterized by FLPs that contain actin bundles and fascin ([Fig. 2 B](#fig2){ref-type="fig"} and Fig. S3 C), followed by prominent transverse actin arcs ([Fig. 2 B](#fig2){ref-type="fig"}). We next stained the cells with antibodies against the known actin-nucleating proteins in lamellipodia and filopodia. Staining with an anti-Arp2 antibody confirmed that although the Arp2/3 complex localizes to the actin-rich lamellipodia of spreading or polarized ARPC3^+/+^ fibroblast cells, it is absent from the tip of the actin bundles in the FLPs in ARPC3^−/−^ cells, and only diffuse cytoplasmic staining was observed ([Fig. 2](#fig2){ref-type="fig"}). As formins are potent actin nucleation factors previously implicated in filopodia formation ([@bib37]; [@bib18]; [@bib36]; [@bib47]; [@bib70]; [@bib6]; [@bib17]), we stained the fibroblasts with antibodies against Diaphanous-related formins (DRF) mDia1 and mDia2. Although neither protein is prominently localized at the lamellipodia in ARPC3^+/+^ fibroblasts, both DRFs were found to localized at the tips of the actin-rich protrusions in ARPC3^−/−^ fibroblasts ([Fig. 2](#fig2){ref-type="fig"} and Fig. S3 C), suggesting that these protrusions might be formed through DRF-mediated actin assembly. Immunoblotting found that the level of mDia1 protein was not drastically different in the mutant compared with the wild type (Fig. S2 E).

ARPC3^−/−^ fibroblasts are defective in wound healing in vitro due to a lack of sustained migration directionality
------------------------------------------------------------------------------------------------------------------

Wound healing is one of the main functions for fibroblasts and requires migration of these cells toward the epithelial wound ([@bib10]; [@bib16]). We used an in vitro assay to assess the ability of ARPC3^−/−^ cells to undergo wound healing. ARPC3^+/+^ and ARPC3^−/−^ fibroblasts were plated at the same densities to form a confluent monolayer before a wound of 300--400 µm was generated by using a culture insert (see Materials and methods). Wound closure was monitored by taking microscopy images at different time points after wound creation. ARPC3^+/+^ cells took ∼30 h to complete wound closure, whereas ARPC3^−/−^ cells showed a considerable delay in wound closure: even after 54 h, the wound reduced in size but was not completely closed ([Fig. 3, A--C](#fig3){ref-type="fig"}). We note that ARPC3^+/+^ and ARPC3^−/−^ fibroblasts are slowly dividing cells with doubling time ∼56 h and limited proliferative potential, and thus cell division was unlikely to contribute significantly to wound closure.

![**ARPC3^−/−^ fibroblast cells in wound healing and their leading edge dynamics.** (A and B) Wound-healing montage of ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells. Bars, 50 µm. (C) Quantification of wound area as a function of time. Plots show mean and standard deviation from six different regions along the wound per experiment and three experiments per genotype. (D) Cell boundary segmentation and illustration of leading edge kymograph line selection. Bars, 25 µm. (E) Each kymograph (left) was digitized (center) and then smoothed for assignment of protrusion and retraction segments. (F) Angular correlation functions were computed as described in Materials and methods. (G) The smaller width at half maximum of the angular correlation function for mutant indicates less coordinated motion of the leading edge than for wild type. Small box shows the mean, line shows median, large box the SEM, and whiskers show SD.](JCB_201112113R_Fig3){#fig3}

Time-lapse phase-contrast movies were made to observe the migration of ARPC3^+/+^ and ARPC3^−/−^ fibroblasts during wound healing. We focused on the behavior of cells at the edge of the wound moving into the open space. As shown in [Video 3](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp6}, ARPC3^+/+^ cells moved toward the wound with leading edges exhibiting the expected lamellipodia morphology (also see [Fig. 3 D](#fig3){ref-type="fig"}). By contrast, ARPC3^−/−^ cells migrated into the wound exclusively with FLP-rich leading edges ([Video 4](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp7} and [Fig. 3 D](#fig3){ref-type="fig"}). To quantitatively compare the dynamics of the leading edge between wild-type and mutant cells we used a kymograph analysis to obtain parameters, including the rate of protrusion or retraction and duration of protrusion or retraction ([Fig. 3, D and E](#fig3){ref-type="fig"}). Surprisingly, this analysis found that ARPC3^−/−^ fibroblasts display significantly faster leading edge protrusion and retraction rates than the corresponding rates of the lamellipodia in ARPC3^+/+^ cells ([Table S1](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp8}). The durations of the protrusion or retraction phases in the mutant cells are also slightly but significantly longer than those in the wild type.

As it was non-obvious that the above parameters describing leading edge dynamics could account for the wound-healing defect observed for ARPC3^−/−^ fibroblasts compared with ARPC3^+/+^ fibroblasts, we went on to analyze whole-cell motility behaviors from long time-lapse movies by tracking the movement of individual ARPC3^+/+^ or ARPC3^−/−^ cells toward the wound area ([Fig. 4, A and B](#fig4){ref-type="fig"}; [Videos 5](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp9} and [6](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp10}). Care was taken to track only those cells moving independently into the wound area, as interaction with neighboring cells could complicate their motility behavior. From these cell tracks, two parameters, path length (L) and displacement (D), were computed ([Fig. 4 C](#fig4){ref-type="fig"}). Dividing L and D by the total trajectory time (*t*) yielded mean movement speed and velocity (a measure of productive displacement rate), respectively. Comparison of these parameters indicated that the average movement speeds between cells of the two genotypes were similar ([Fig. 4 D](#fig4){ref-type="fig"}), but the wild-type cells moved with a considerably higher velocity ([Fig. 4 E](#fig4){ref-type="fig"}). Thus, although wild-type and mutant cells were similarly motile, the motility of mutant cells did not lead to displacement efficiently. The D/L ratio is a measure of the straightness of each cell track and showed that the paths of ARPC3^−/−^ fibroblasts were significantly less straight than those of wild-type cells ([Fig. 4 F](#fig4){ref-type="fig"}). This result suggests that the mutant cells have a deficiency in sustaining the directionality of the movement.

![**Migration behavior of individual ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells during wound closure.** (A and B) Aggregated trajectories of ARPC3^+/+^ (A) and ARPC3^−/−^ (B) fibroblast cells migrating for 10 h toward the wound center. (C) Visual demonstration of path length vs. displacement for speed and velocity calculations. (D) Cell speed, (E) velocity, and (F) straightness of wild-type and mutant cells. Notation is as in [Fig. 3 G](#fig3){ref-type="fig"}. (G) A plot of MSD vs. time shift and (H) α values from MSD curve fits indicating more directed motion for ARPC3^+/+^ cells (solid line) than for ARPC3^−/−^ cells (dashed line). Dotted line represents the case for α = 1 indicating pure random motion.](JCB_201112113_Fig4){#fig4}

To assess this further, we performed a mean square displacement (MSD) analysis of the cell-tracking data. The MSD was calculated using the equation:$$MSD\left( \tau \right) = \left\langle \left| {\overset{\rightarrow}{r}\left( t + \tau \right) - r\left( t \right)} \right|^{2} \right\rangle,$$where $\overset{\rightarrow}{r}\left( t \right)$ is the position of the cell at time *t*. The result was fitted to *MSD*(τ) = 4*D*τ^α^, where *D* is the diffusion coefficient and the exponent *α* indicates the degree of directional motion. The resulting average MSD curve for wild-type cells showed an upward trend and the corresponding *α* value was 1.43 ± 0.05, indicating directional motion, whereas the MSD plot for the mutant cells was nearly linear with an *α* value of 1.09 ± 0.09, not significantly deviating from *α* = 1 for pure random walk (P-value = 0.14; [Fig. 4, G and H](#fig4){ref-type="fig"}). Consistent with these quantitative analyses, observation of cell movement in the time-lapse movies also gave the impression that the mutant cells had a reduced ability to maintain a consistent leading edge (compare Videos 3 and 4), possibly as a result of the independently protruding and retracting FLPs, as opposed to the apparently more coordinated dynamics of lamellipodia of ARPC3^+/+^ cells. To assess the level of coordination at the leading edge, we calculated the spatial (angular) correlations of leading edge protrusion and retraction dynamics in the migrating ARPC3^+/+^ and ARPC3^−/−^ cells from the kymographs in [Fig. 3](#fig3){ref-type="fig"} (see Materials and methods for details). This analysis found the amplitude of the correlation to be in general much higher in the wild-type cells than in the mutant cells ([Fig. 3 F](#fig3){ref-type="fig"}), and the characteristic angular distance for correlation decay was also larger in the wild type than that in the mutant ([Fig. 3 G](#fig3){ref-type="fig"}). This analysis indicates poor coordination of protrusion and retraction dynamics at the mutant cell leading edge and provides a possible explanation for the lack of directional persistence in the movement of ARPC3^−/−^ fibroblasts.

ARPC^−/−^ fibroblasts are defective in chemotaxis in response to an EGF gradient
--------------------------------------------------------------------------------

Because the environment in a wound-healing assay is complex and the cells may not be experiencing a robust directional cue, we further tested the ability of ARPC3^−/−^ fibroblasts to undergo directional migration in a chemotaxis assay along a gradient of EGF. We first tested the ability of ARPC3^+/+^ and ARPC3^−/−^ cells to respond to uniform EGF. Wild-type fibroblasts responded within minutes of EGF (25 ng/ml) stimulation with slightly but apparently more vigorous lamellipodia protrusions and retractions ([Video 7](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp11}), and interestingly, this response was even more pronounced in ARPC3^−/−^ cells ([Video 8](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp12}, [Table S2](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp13}). A stable EGF gradient was established by using the microfluidics device μ-Slide (Ibidi; see Materials and methods). The motility of cells in the presence of the EGF gradient was tracked for 12 h. ARPC3^+/+^ cells migrated up the gradient as expected, with 85% of cells moving closer to the EGF source at the end of the observation ([Fig. 5 A](#fig5){ref-type="fig"}, [Video 9](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp14}). By contrast, the mutant cells failed chemotaxis with only 48% cells moving closer to the EGF source ([Fig. 5 B](#fig5){ref-type="fig"}, [Video 10](http://www.jcb.org/cgi/content/full/jcb.201112113/DC1){#supp15}). Analysis of the parameters describing single cell movement (as in [Fig. 4](#fig4){ref-type="fig"}) found again that the mutant cells failed to sustain movement directionality and exhibited mostly random walk in the presence of the EGF gradient ([Fig. 5, C--F](#fig5){ref-type="fig"}).

![**Chemotaxis of ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells in response to an EGF gradient.** The ARPC3^+/+^ and ARPC3^−/−^ cells were plated on fibronectin-coated μ-Slide and analyzed for 12 h in the presence of EGF gradient (500 ng/ml at source). (A and B) Aggregated trajectories of individual ARPC3^+/+^ (A) and ARPC3^−/−^ (B) cells in the presence of the EGF gradient. (C) Cell speed, (D) velocity, (E) straightness, and (F) MSD α values for wild-type and mutant cells presented as in [Fig. 4](#fig4){ref-type="fig"}. The data came from tracking of 43 (two experiments) ARPC3^+/+^ and 115 (five experiments) ARPC3^−/−^ cells.](JCB_201112113_Fig5){#fig5}

Taken together, the analysis of ARPC3^−/−^ fibroblasts in comparison with ARPC3^+/+^ fibroblasts described above provides the functional evidence supporting the notion that the Arp2/3 complex plays a critical role in the formation of lamellipodia. However, without the Arp2/3 complex the fibroblasts cells were still able to form dynamic membrane protrusions with filopodia-like morphology. Detailed ultrastructural analysis will be necessarily to determine if the FLPs observed in ARPC3^−/−^ fibroblasts are indeed the stereotypical filopodia ([@bib40]; [@bib54]; [@bib21]), and future work with other Arp2/3 complex subunit mutants should help ascertain that ARPC3^−/−^ represents complete Arp2/3 complex null. Interestingly, a recent study found that WAVE and the Arp2/3 complex jointly inhibits mDia2-mediated filopodia formation through a physical interaction with mDia2 ([@bib4]), providing a possible explanation of the abundant FLP formation and prominent localization of DRF proteins at the tip of these processes in ARPC3^−/−^ cells.

A surprising result of our study is that ARPC3^−/−^ cells are capable of rapid spreading and are highly motile despite the lack of lamellipodia. The mutant fibroblasts exhibited a movement speed comparable to (in wound healing) or even faster than (in the presence of EGF) that of wild-type fibroblasts. This correlates with more vigorous FLP dynamics (higher protrusion and retraction rates) at the leading edge of the mutant fibroblasts than those at the leading edge of lamellipodia in wild-type cells. However, a glaring defect of the mutant cells was their inability to undergo persistent directional movement, leading to a considerable delay in wound healing compared with wild-type cells. We speculate that this deficiency may be intrinsic to the FLP-based leading edge. Correlation analysis found poor coordination in the protrusion and retraction dynamics between neighboring positions on the leading edge in the mutant cells, possibly as a consequence of independent nucleation, elongation, and retraction of individual FLPs. This lack of coordination could possibly increase the chance of stochastic switch of the directionality of leading edge extension. By contrast, the protrusion and retraction dynamics are highly coordinated along the leading edge of ARPC3^+/+^ fibroblasts, likely as a consequence of the auto-catalytic, dendritic actin nucleation mediated by the Arp2/3 complex, whereby the nucleation of a new filament is favored in the vicinity of other elongating actin filaments at the leading edge. This finding suggests that Arp2/3 complex-mediated lamellipodia extension may be particularly favorable to cell migration processes that require strong directional persistence.

Using a chemotaxis assay in the presence of an EGF gradient, we found that ARPC3^−/−^ fibroblasts are deficient in directional cell migration even in the presence of a stable directional cue. The explanation for this defect may be more complex than that for the delayed wound healing. Although a lack of leading edge coordination could contribute to frequent turning from the expected direction, a lack of any observable bias in cell movement may suggest that the cell's ability to recognize and amplify the external gradient was also disrupted in the absence of Arp2/3-mediated actin assembly. The ARPC3^−/−^ cells were able to respond to EGF stimulation by forming more dynamic FLPs, but a failure in gradient sensing in these cells could be due to the disruption of a feedback loop from the Rac--Arp2/3 pathway of actin assembly to the upstream signaling events, which in neutrophils plays an important role in amplifying the directional cue from chemoattractant gradient ([@bib13]; [@bib60]; [@bib62]; [@bib52]).

In summary, using mouse gene-disruption technology and ES cell differentiation we have performed a detailed analysis comparing the motility behavior of fibroblast cells in the presence or absence of a functional Arp2/3 complex. Our results demonstrate a critical role for the Arp2/3 complex in the assembly of lamellipodia-based leading edges and directional cell motility. As ES cells can be differentiated into a wide array of motile cells such as neutrophils, dendritic cells, and neurons ([@bib12]; [@bib5]; [@bib25]), the model system established in this work should be useful for dissecting the function of the Arp2/3 complex in motile cells and unraveling the evolution design principles in the machineries that drive diverse cell motility processes.

Materials and methods
=====================

Generation and analysis of ARPC3^+/−^ gene-trap mice
----------------------------------------------------

ES cell clone (XG476) carrying the ARPC3 gene disruption was purchased from the Bay genomics (version CC183108.1) and were injected into the blastocyst of the C57BL6 blastocysts (3.5 dpc) with Nikon micromanipulators. The blastocysts were cultured in KSOM+AA for 2--3 h and were transplanted into the uterus of 2.5(dpc) pseudo-pregnant recipient F1 mothers (CBAXC57Bl/10). The offspring born with agouti coat color reflect the contribution of the ES cells to the developing embryo. Successful transmission of the mutation was initially determined by mating the chimeras to wild-type C57BL/6 females. Offspring with agouti coat color represent the transmission of the 129 ES cell background and were genotyped to identify the presence of the mutated allele. The mouse line was further established by intercrossing the heterozygous male and females. The ARPC3^+/−^ line was established by backcrosses with mice of the C57BL/6 genetic background.

ARPC3^+/+^, ARPC3^+/−^, and ARPC3^−/−^ ES cell derivation and maintenance
-------------------------------------------------------------------------

ARPC3^+/−^ females (4--8 wk old) were mated with (ARPC3^+/−^) males. The uterine horns and uterus were dissected from the 3.5-d pregnant female mice and the blastocysts were collected in M2 medium and washed and cultured in a drop of KSOM+AA media overlaid with mineral oil at 37°C in a humidified atmosphere with 5% CO~2~. ES cell derivation was performed with slight modification of the protocols described previously ([@bib11]). In brief, blastocyst zonae pellucidae was removed by treating with acidic Tyrode's solution (Millipore) and washed with KSOM+AA medium. The blastocysts were transferred individually into individual wells of 4-well IVF plates (Thermo Fisher Scientific) coated with 0.1% (wt/vol) gelatin and filled with a layer of iMEF (Global Stem) in 500 µl of ES cell derivation medium. This medium contains Knockout DMEM (Invitrogen), 20% Knockout FBS (Invitrogen), 2 mM [l]{.smallcaps}-glutamine (Invitrogen), 50 U/ml penicillin/50 µg/ml streptomycin (Invitrogen), 0.1 mM β-mercaptoethanol (BD), 0.1 mM MEM nonessential amino acids (Invitrogen), 1,000 U/ml recombinant mouse LIF (Millipore), and mitogen-activated protein kinase inhibitor (PD98059; Cell Signaling Technology) at 37°C in an incubator with 5% CO~2~. The blastocysts were allowed to attach to the iMEF feeder layer without disturbance for 6 d and cultured up to 12 d by changing the ES derivation medium every second day. The inner cell mass was mechanically detached using a glass pipette tip and transferred into a 12-well plate containing iMEFs. The ES cell colonies were cultured further, washed with calcium- and magnesium-free PBS, and trypsinized with 0.25% trypsin/EDTA for 2--5 min at 37°C. The cells were centrifuged and transferred into a 6-well plate and cultured in Knockout DMEM-FBS medium until they were confluent. At this stage, each ES clone was plated in duplicates in 6-well plates with one set being used for genotyping and the other for further colony expansion. To scale up the ES cell culture, cells were cultured in T75 flasks filled with iMEF and Knockout DMEM-FBS medium until they reached 70--80% confluence. The ES cells were frozen in 10% DMSO and 90% FBS and stored in liquid nitrogen.

ES cell differentiation into fibroblast using retinoic acid
-----------------------------------------------------------

ARPC3^+/−^ and ARPC3^−/−^ ES cells were separated from the iMEFs by transferring into a new dish every 45 min, taking advantage of the fact that iMEFs are more adherent. The ES cells in supernatant were spun down at 1,000--1,200 rpm for 5 min and used either for genotyping or differentiation. The ES cells were seeded into pregelatin-coated T75 flask(s) or 150-mm dishes with ES cell medium containing LIF. Cells were allowed to settle down on plates overnight and replaced with fibroblast medium (DMEM high-glucose \[Invitrogen\], 10% FBS, 1% nonessential amino acids \[Invitrogen\], 0.1% 2-mercaptoethanol, 50 U/ml penicillin, and 50 µg/ml streptomycin) containing 3.33 × 10^7^ M (0.33 µM) retinoic acid ([@bib49]). The media was changed twice at 24-h intervals. Cells were cultured for up to 7 d, with daily changes of medium after the initial 72 h. Undifferentiated ES cells were separated from the fibroblasts by consecutive transfer to a new dish every 30 min. The fibroblast cells re-adhere to the substrate faster than the undifferentiated ES cells. The differentiated fibroblast cells were able to survive for ∼10 d after 7 d of differentiation and 2--3 passages.

Genotyping of ARPC3^+/+^ and ARPC3^−/−^ ES cells and fibroblast cells and RT-PCR
--------------------------------------------------------------------------------

Genomic DNA from ARPC3^+/+^, ARPC3^+/−^, and ARPC3^−/−^ ES cells and fibroblast cells was isolated by homogenizing the cells in 20--40 µl extraction buffer and 5--10 µl tissue preparation buffer (Sigma-Aldrich). Homogenized samples were incubated for 20 min at room temperature, 5 min at 95°C, and then neutralized with 20--40 µl of neutralization buffer. The supernatant was used for the PCR genotyping using Red extract PCR mixture (Sigma-Aldrich) with the following primers: P1: ARPC3-Wt-F 5′-TGCAGGCATACCACTCTTCTCTCA-3′; P2: ARPC3-Wt-R 5′-AGCACCACGAATTGAGGCTAGAGT-3′; and P3: ARPC3-GT-R 5′-AAAGGGTCTTTGAGCACCAGAGGA-3′.

RT-PCR analysis in fibroblast cells was performed by isolating the total RNA from ARPC3^+/+^, ARPC3^+/−^, and ARPC3^−/−^ fibroblasts using an RNA extraction kit (QIAGEN). cDNA was synthesized from total RNA using Superscript III (Invitrogen) reverse transcription with random hexamer primers (Invitrogen). To examine the expression of ARPC3 wild-type or gene-trap truncated mRNA, cDNA was amplified using the following primers: P4: Xg476-wt-E2F 5′-GGACACCAAGCTCATCGGTAACAT-3′; P5: Xg476-wt-E4R 5′-GATGTAGATCAATGTCCTGTCCGC-3′; and P6: Xg476-βgeo-R 5′-ATTCAGGCTGCGCAACTGTTGGG-3′.

Immunofluorescence staining
---------------------------

ARPC3^+/−^, ARPC3^+/−^, and ARPC3^−/−^ ES cells were cultured on a 0.1% (wt/vol) gelatin-coated glass-bottom dish for 3 d. Cells were washed and fixed with 4% paraformaldehyde in PBS for 25 min. Fixed cells were permeabilized by treatment with PBS/0.1% Tween 20 for 5 min and blocked by incubation with 3% BSA in PBS for 1 h. Cells were then incubated in PBS with 3% BSA containing Oct4 antibodies (mouse; Abcam) at a dilution of 1:100 overnight at 4°C. Cells were washed three times with PBS/0.1% Tween 20 and then incubated for 1 h with Alexa 488--conjugated mouse anti--rabbit secondary antibody at a dilution of 1:300 for 45 min at 37°C. Cells were washed with PBS/ 0.1% Tween 20 and then counterstained with fluorescent phalloidin (Invitrogen) for actin filaments and DAPI for DNA. The cells were mounted and imaged under a confocal microscope (LSM-510-LIVE; Carl Zeiss).

ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells were grown on glass coverslips (or) glass-bottom dishes for 24 h. Two different fixation protocols were used. For staining IB10, Arp2, and mDia1, the cells were fixed with 4% paraformaldehyde in PBS at 37°C for 30 min. After fixation and permeabilization as described above, cells were blocked with fetal bovine serum or 3% BSA for 1 h and incubated with the primary antibodies against: IB10 (1:75; Abcam), Arp2 (1:200 and 1:75 for two different batches; Santa Cruz Biotechnology, Inc.), ARPC3 (1:50; BD), and mDia1 (1:200; Santa Cruz Biotechnology, Inc.) overnight at 4°C. After three washes with PBS/ 0.2% Tween 20, the cells were incubated with a corresponding secondary antibody coupled to Alexa Fluor 488 (Invitrogen) at a dilution of 1:300 at 37°C for 1 h. Cells were washed with PBS/0.2% Tween 20 and then counterstained with Alexa Fluor 546 phalloidin (Invitrogen) and DAPI. For straining with anti-mDia2 (a gift from Dr. S. Narumiya, Kyoto University, Kyoto, Japan), cells were fixed with 10% TCA on ice for 15 min as described in [@bib61]. The fixed cells were washed with PBS containing 30 mM glycine (G-PBS) and permeabilized with 0.2% Tween 20 in G-PBS for 5 min on ice, followed by three washes with G-PBS and processed as described above. For fascin antibody (1:50; Millipore) staining, the cells were fixed with methanol at −20°C for 15 min.

Alkaline phosphatase assay
--------------------------

ARPC3^+/−^, ARPC3^+/−^, and ARPC3^−/−^ ES cells were cultured and fixed with 4% paraformaldehyde in PBS for 30 min at 37°C. Cells were washed in PBS and incubated with recommended substrate solutions (Vector Laboratories) for 20--30 min at room temperature until sufficient staining developed. Cells were imaged under a microscope (Axiovert; Carl Zeiss) using Plan Neofluor 10x/0.30 Ph1 (DIC I) 10x objectives.

Cell spreading and wound-healing assays
---------------------------------------

For observing cell spreading, ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells were trypsinized with 0.05% trypsin/EDTA for 5 min and centrifuged. The cells were resuspended in fibroblast medium and placed on a glass-bottom dish (MatTek Corp.) coated with 5 µg/ml of bovine fibronectin (Sigma-Aldrich) for 20 min in a 37°C incubator. The cell spreading was recorded on a microscope equipped with a 37°C incubator and 5% CO~2~ for a period of 2 h with frames taken every 2 min. Phase-contrast imaging was performed either with a microscope (LSM-510; Carl Zeiss) equipped with a Plan-Apochromat 20x/0.6 Ph2 air objective (Carl Zeiss) or with a microscope (Eclipse TE2000-E; Nikon) equipped with a Plan-Fluar 10x Ph1 DLL objective and a CCD camera (CoolSNAP; Photometrics). For the LSM-510 microscope, images were collected using the maximum field of view and 512 × 512 image size. The overall spreading area was measured by outlining the cell boundary every 10 frames using custom ImageJ segmentation software (described below).

For the wound-healing assay, ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells were cultured in fibroblast medium as described previously. Glass-bottom dishes were coated with 5 µg/ml fibronectin at 37°C for 1--2 h, washed with PBS, and attached to a culture insert (Ibidi). Fibroblast cells were trypsinized with 0.05% trypsin for 5 min, centrifuged, and resuspended in fibroblast medium. The cells suspensions (85 µl) were seeded at a density of 1.5--2.0 × 10^5^ cells/ml and cultured overnight at 37°C with 5% CO~2~. The next day, cells were rinsed with PBS at least twice and switched to DMEM with 0.5% serum for 12 h. The culture insert was removed to create the "wound", and cells were rinsed with PBS and fed with fibroblast culture medium supplemented with 10% FBS. The wounds were imaged with phase contrast on the LSM-510 microscope using a Plan-Neofluar 10x/0.30 Ph1 objective at different time points, and healing was quantified by manually measuring the wound areas that remained using Axiovision software (Carl Zeiss). For the cell-tracking analysis movies were made for 10 h with frames taken every 10 min; leading edge dynamics movies were 1.5 h long with an interval of 3 s/frame.

Chemotaxis assay
----------------

Chemotaxis was assayed following Ibidi protocol with several modifications. In brief, ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells were trypsinized and counted. The cell suspension was diluted to ∼3 × 10^6^ cells/ml. The μ-Slide Chemotaxis slides (Ibidi) were coated with 5 µg/ml of fibronectin at 37°C for 1--2 h and washed with PBS. The C, D, E, and F ports were closed with plugs and 6 µl of cell suspension was applied onto filling port (A) of the μ-Slide using a 20-µl pipettor and 6 µl of air was aspirated from the opposite filling port (B). The slide was placed in a sterile 10-cm Petri dish with a wet tissue around the slide and incubated in the tissue culture hood for 15 min and transferred to a 37°C incubator until the cells were attached. All plugs were gently removed from the filling ports and both reservoirs were filled with 70 µl chemoattractant-free medium. One of the filling ports was filled with 18 µl chemoattractant (500 ng/ml EGF) solution by removing 18 µl of medium from the other port on the same side of the device. Once again, all the ports were closed with plugs. Cell migration was recorded by mounting the μ-Slide on the stage of an inverted microscope with a 37°C incubator and 5% CO~2~. For the trajectory analysis, movies were made using the LSM-510 microscope with an A-Plan10x/0.25 Ph1 air objective or the Eclipse TE2000-E microscope as described above for a period of 12 h with frames taken every 10 min.

Cell trajectory analysis
------------------------

Movies were acquired on an inverted microscope as described above in the wound-healing and chemotaxis assay sections. To generate the trajectories for the wound-healing assay, single cells at the wound edge were tracked by manually selecting the nucleus throughout the movie using a custom plug-in written for ImageJ (National Institutes of Health \[NIH\], Bethesda, MD). For the chemotaxis assay, single cells were tracked by selecting the center of mass throughout the length of the movie using the Chemotaxis and Migration tool for ImageJ from Ibidi. For both assays, speed, velocity, straightness, and α value were obtained by using Mathematica software (Wolfram Research Inc.). The trajectory path length and the displacement from the initial to the end point of each trajectory was computed. The speed and mean velocity are given by the ratio of the path length and the displacement to the total trajectory time, respectively. The trajectory straightness is computed as the ratio of displacement to path length. The mean squared displacement was found for each trajectory according to the following formula:$$MSD\left( \tau \right) = \left\langle \left| {\overset{\rightarrow}{r}\left( t + \tau \right) - \overset{\rightarrow}{r}\left( t \right)} \right|^{2} \right\rangle,$$where $\overset{\rightarrow}{r}\left( t \right)$ is the two-dimensional position at time *t*, and \< \> denotes time averaging. This quantity was fit by nonlinear least squares to the following general formula: *MSD*(τ) = 4*D*τ^α^, where *D* is the apparent diffusion coefficient and α is a factor indicating nonrandom diffusion. For purely random motion (e.g., Brownian diffusion), α is 1 and MSD follows a straight line. For directed motion, α is greater than 1, and for confined motion α is smaller than 1.

Cell segmentation
-----------------

For analysis methods involving leading edge tracking (cell spreading or leading edge dynamics), phase-contrast images were segmented using a custom plug-in written for ImageJ, which links to the OpenCV library (Willow Garage) following the example of the CellTrack program ([@bib44]). In brief, each phase-contrast image frame was processed by first performing Canny edge detection followed by a single binary dilation. Subsequently, the binary image was outlined using the cvFindContours subroutine of OpenCV. Finally, the outline containing the largest area was selected and filled to create a cell mask.

Kymograph analysis
------------------

For the kymograph analysis of leading edge dynamics, phase-contrast time-lapse movies were made with the LSM-510 microscope using a Plan-Apochromat 20x/0.6 Ph2 air objective for a period of 1.5 h with frames taken every 3 s. The cells chosen for analysis were single cells migrating in the wound. These cells were cropped from the full-size images and the leading edge boundary was masked frame by frame (see above) to reduce noise without altering the position of the cell edge. Masked images were further processed by automatic generation of several equally spaced (5° in angular measure) 1-pixel-wide lines from a manually chosen central point to the leading edge of the cell and subsequent calculation of the distance to the leading edge along each line in the direction of individual protrusions using a custom-written ImageJ plug-in. We note that the protrusion and retraction rate determined using this plug-in was confirmed by those determined with manual kymographs of the FLPs in the mutant cells. The distances generated above were subsequently analyzed using Mathematica software. Each kymograph was smoothed using a moving averaging window of 30 time points and regions of leading edge protrusion and retraction were determined as follows. First, the smoothed kymograph was segmented into 10 time point segments. The slopes of these segments were calculated from the starting and ending points of the segments. Slopes between 10% and −10% of the maximal and minimal slope for each trajectory were eliminated. Segments with contiguous regions with slopes of the same sign were flagged as protruding (positive slope) or retracting (negative slope). The durations and average slopes of these contiguous regions were averaged to give the final duration and rate measurements for each trajectory. In addition, for each time step the angular correlation *C*(*ψ*) of the leading edge dynamics was computed. This quantity is defined as:$$C\left( \psi \right) = \left\langle v\left( \phi \right)v\left( \phi - \psi \right) \right\rangle,$$where *ν*(*ϕ*) is the velocity as a function of angular position *ϕ* along the leading edge, *ψ* is the angular shift, and \< \> denotes averaging over *ϕ*. If the adjacent regions of the leading edge are concerted in velocity the width of the angular correlation function (at half of its maximal value) is large, whereas for uncorrelated velocity distributions this width tends to zero.

Online supplemental material
----------------------------

Fig. S1 shows generation of ARPC3^+/−^ gene-trap mouse and ARPC3^+/+^ and ARPC3^−/−^ ES cells. Fig. S2 shows characterization of ARPC3^+/+^ and ARPC3^−/−^ ES cells. Fig.S3 shows characterization of ARPC3^+/+^ and ARPC3^−/−^ fibroblast cells by immunofluorescence staining. Video 1 shows a spreading ARPC3^+/+^ fibroblast cell. Video 2 shows a spreading ARPC3^−/−^ fibroblast cell. Video 3 shows ARPC3^+/+^ fibroblast cells migrating toward the wound. Video 4 shows ARPC3^−/−^ fibroblast cells migrating toward the wound. Video 5 shows trajectories of individual ARPC3^+/+^ fibroblast cells during wound closure. Video 6 shows trajectories of individual ARPC3^−/−^ fibroblast cells. Video 7 shows ARPC3^+/+^ fibroblast cells responding to stimulation with 25 ng/ml EGF. Video 8 shows ARPC3^−/−^ fibroblast cells responding to stimulation with 25 ng/ml EGF. Video 9 shows trajectories of individual ARPC3^+/+^ fibroblast cells migrating in the presence of an EGF gradient. Video 10 shows trajectories of individual ARPC3^−/−^ cells migrating in the presence of an EGF gradient. Table S1 shows leading edge protrusion and retraction rates and durations. Table S2 shows quantification of leading edge dynamics. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201112113/DC1>.
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